Yposkesi, la filiale de SK pharmteco spécialisée dans la fabrication de vecteurs viraux cliniques et commerciaux pour la thérapie cellulaire et génique (C>), achève sa deuxième installation de bioproduction et double sa surface de production pour atteindre 10 000 m2, l’une des plus…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.